Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 4 |
Forrest at al. (procyclic) | yes | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I8W8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 170 | 174 | PF00656 | 0.589 |
CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.745 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.532 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.532 |
DOC_PP4_FxxP_1 | 143 | 146 | PF00568 | 0.391 |
DOC_PP4_FxxP_1 | 150 | 153 | PF00568 | 0.378 |
DOC_USP7_MATH_1 | 17 | 21 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.592 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.765 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.454 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.586 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.616 |
LIG_BRCT_BRCA1_1 | 146 | 150 | PF00533 | 0.403 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.730 |
LIG_LIR_Apic_2 | 139 | 145 | PF02991 | 0.408 |
LIG_LIR_Apic_2 | 147 | 153 | PF02991 | 0.432 |
LIG_LIR_Apic_2 | 156 | 161 | PF02991 | 0.446 |
LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.332 |
LIG_PDZ_Class_3 | 172 | 177 | PF00595 | 0.606 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.382 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.600 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.748 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.617 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.645 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.679 |
MOD_CK2_1 | 169 | 175 | PF00069 | 0.580 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.663 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.594 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.617 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.565 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.604 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.580 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.669 |
MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.636 |
MOD_N-GLC_1 | 61 | 66 | PF02516 | 0.634 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.552 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.617 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.557 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.578 |
MOD_Plk_2-3 | 169 | 175 | PF00069 | 0.587 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.445 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.587 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.614 |
MOD_SPalmitoyl_4 | 1 | 7 | PF01529 | 0.557 |
MOD_SUMO_for_1 | 126 | 129 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 79 | 87 | PF00179 | 0.624 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.320 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.618 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I074 | Leptomonas seymouri | 54% | 100% |
A0A3S7X6J5 | Leishmania donovani | 100% | 100% |
A4HLF7 | Leishmania braziliensis | 49% | 100% |
D0A4W3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9B3T7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q4Q487 | Leishmania major | 84% | 100% |